FRA:9R5 (Sweden)
Â
Unit (1 Ordinary share & 1 Wrt)
€
0.0010
(0%)
Jul 31
Business Description
Spermosens AB
ISIN : SE0015346424
Share Class Description:
FRA:9R5: Unit (1 Ordinary share & 1 Wrt)Total Employee Number:
3Compare
Compare
Traded in other countries / regions
SPERM.Sweden9R5.Germany IPO Date
2023-07-14Description
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 77.2 | |||||
3-Year EPS without NRI Growth Rate | 77.3 | |||||
3-Year FCF Growth Rate | 77.7 | |||||
3-Year Book Growth Rate | -45.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.49 | |||||
9-Day RSI | 36.65 | |||||
14-Day RSI | 43.45 | |||||
12-1 Month Momentum % | -83.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.3 | |||||
Quick Ratio | 4.3 | |||||
Cash Ratio | 3.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -27.03 | |||||
ROA % | -25.92 | |||||
ROIC % | -32.96 | |||||
3-Year ROIIC % | 56.72 | |||||
ROC (Joel Greenblatt) % | -2718.33 | |||||
ROCE % | -27.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 1.02 | |||||
EV-to-EBIT | -2.76 | |||||
EV-to-EBITDA | -2.82 | |||||
EV-to-FCF | -3.17 | |||||
Earnings Yield (Greenblatt) % | -36.13 | |||||
FCF Yield % | -24.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spermosens AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 429.46 | ||
| 14-Day RSI | 43.45 | ||
| 14-Day ATR (€) | 0.000168 | ||
| 20-Day SMA (€) | 0.00156 | ||
| 12-1 Month Momentum % | -83.33 | ||
| 52-Week Range (€) | 0.0002 - 0.0084 | ||
| Shares Outstanding (Mil) | 3,173.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spermosens AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spermosens AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 102 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 18 days | ||
| General meeting for 2026 | 2026-06-18 10:00 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-05-29 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-11 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-20 | 0.00 (+0.00%) | ||
| General meeting for 2025 | 2025-06-16 10:00 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-05-26 | 0.00 (+0.00%) |
Show
Entries
Spermosens AB Frequently Asked Questions
What is Spermosens AB(FRA:9R5)'s stock price today?
The current price of FRA:9R5 is €0.00. The 52 week high of FRA:9R5 is €0.01 and 52 week low is €0.00.
When is next earnings date of Spermosens AB(FRA:9R5)?
The next earnings date of Spermosens AB(FRA:9R5) is 2026-08-20.
Does Spermosens AB(FRA:9R5) pay dividends? If so, how much?
Spermosens AB(FRA:9R5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Spermosens AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers